N/A
Manufactured by Rowpar Pharmaceuticals, Inc.
808 FDA adverse event reports analyzed
Last updated: 2026-04-15
HYDROGEN PEROXIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rowpar Pharmaceuticals, Inc.. The most commonly reported adverse reactions for HYDROGEN PEROXIDE include DRUG INEFFECTIVE, NAUSEA, FATIGUE, PRURITUS, HEADACHE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for HYDROGEN PEROXIDE.
Out of 311 classified reports for HYDROGEN PEROXIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 808 FDA FAERS reports that mention HYDROGEN PEROXIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, NAUSEA, FATIGUE, PRURITUS, HEADACHE, VOMITING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Rowpar Pharmaceuticals, Inc. in connection with HYDROGEN PEROXIDE. Always verify the specific product and NDC with your pharmacist.